| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $40.5M | +4.6% | -33.2% |
| SG&A Expense | $12.2M | -20.5% | -24.0% |
| Operating Income | -$57.7M | -6.8% | +24.7% |
| Pre-tax Income | -$56.8M | -7.7% | +21.7% |
| Income Tax | $0 | -100.0% | -100.0% |
| Net Income | -$56.8M | -7.6% | +21.8% |
| EPS (Basic) | -$0.35 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $129.1M | +3.7% | -53.2% |
| Short-term Investments | $42.5M | -54.4% | -35.3% |
| Current Assets | $177.1M | -20.6% | -49.2% |
| Total Assets | $177.8M | -20.5% | -49.6% |
| Current Liabilities | $25.8M | +22.1% | -18.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$158.5M | — | — |
| Capital Expenditures | $16K | — | — |
| Investing Cash Flow | $125.9M | — | — |
| Financing Cash Flow | $18.3M | — | — |
| Free Cash Flow | -$158.5M | — | — |
| -6.1% |
| +22.2% |
| EPS (Diluted) | -$0.35 | -6.1% | +22.2% |
| $19.6M |
| +0.6% |
| — |
| Total Liabilities | $45.7M | +11.5% | +43.6% |
| Stockholders' Equity | $132.2M | -27.7% | -58.8% |